New study shows algae beta-glucan ingredient supports immune health
A recent immune-health clinical trial focused on BetaVia™ Complete, the proprietary strain of Euglena gracilis from Kemin Industries, showed that people supplementing with BetaVia Complete had 70 percent fewer upper respiratory tract infection (URTI) symptoms, nearly four less sick days and 10 fewer URTI symptom days over a 90-day period.
The 90-day randomized, double-blind, placebo-controlled clinical trial used the validated Wisconsin Upper Respiratory Symptoms Survey (WURSS) to collect self-reported information on active adults’ URTI experience. The WURSS assesses symptoms, symptom severity and functional impact associated with URTI. Statistically significant results showed fewer sick days, fewer URTI symptoms and fewer days experiencing symptoms with BetaVia Complete, compared to the placebo group.
BetaVia Complete, which supports a healthy immune system, is the newest addition to Kemin Human Nutrition and Health’s portfolio of functional ingredients. BetaVia Complete is a proprietary, nutrient-rich algae (Euglena gracilis) with greater than 50 percent 1,3 beta glucan content. Grown in the Kemin-patented fermentation process, BetaVia Complete supports immune health by priming key immune cells, promoting cell signaling and providing nutritional support.